Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Week in Review

Summaries of each week's events in China biotech are provided free to all readers.  A weekly email newsletter providing direct links to these articles is also available - click here for free email newsletter...

Week in Review: Abbisko Raises $70 Million to Develop Cancer Drug Candidates

Week in Review: InnoCare Prices Hong Kong IPO to Raise $288 Million

Week in Review: Nanjing Legend Files to Stage IPO in the US

Week in Review: Abpro Bio Signs $1.1 Billion Deal for China-Asian Rights to Two Bi-specifics

Week in Review: CICC Capital Closes $229 Million China Fund for Biologics

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China